1XU2 image
Deposition Date 2004-10-25
Release Date 2004-11-09
Last Version Date 2024-10-16
Entry Detail
PDB ID:
1XU2
Title:
The crystal structure of APRIL bound to BCMA
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.35 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tumor necrosis factor ligand superfamily member 13
Gene (Uniprot):Tnfsf13
Chain IDs:A, B, C (auth: D)
Chain Length:138
Number of Molecules:3
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Tumor necrosis factor receptor superfamily member 17
Gene (Uniprot):TNFRSF17
Chain IDs:D (auth: R), E (auth: S), F (auth: T)
Chain Length:47
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structures of APRIL-receptor complexes: Like BCMA, TACI employs only a single cysteine-rich domain for high-affinity ligand binding
J.Biol.Chem. 280 7218 7227 (2005)
PMID: 15542592 DOI: 10.1074/jbc.M411714200

Abstact

TACI is a member of the tumor necrosis factor receptor superfamily and serves as a key regulator of B cell function. TACI binds two ligands, APRIL and BAFF, with high affinity and contains two cysteine-rich domains (CRDs) in its extracellular region; in contrast, BCMA and BR3, the other known high affinity receptors for APRIL and BAFF, respectively, contain only a single or partial CRD. However, another form of TACI exists wherein the N-terminal CRD is removed by alternative splicing. We find that this shorter form is capable of ligand-induced cell signaling and that the second CRD alone (TACI_d2) contains full affinity for both ligands. Furthermore, we report the solution structure and alanine-scanning mutagenesis of TACI_d2 along with co-crystal structures of APRIL.TACI_d2 and APRIL.BCMA complexes that together reveal the mechanism by which TACI engages high affinity ligand binding through a single CRD, and we highlight sources of ligand-receptor specificity within the APRIL/BAFF system.

Legend

Protein

Chemical

Disease

Primary Citation of related structures